{"document_type": "article", "byline": {"person": [{"role": "reported", "firstname": "Robert", "organization": "", "rank": 1, "lastname": "CYRAN"}], "original": "By ROBERT CYRAN"}, "news_desk": "Business", "slideshow_credits": null, "abstract": null, "multimedia": [{"type": "image", "url": "images/2016/03/16/business/16valeantsub/16valeantsub-thumbWide.jpg", "legacy": {"wide": "images/2016/03/16/business/16valeantsub/16valeantsub-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "width": 190, "subtype": "wide", "height": 126}, {"type": "image", "url": "images/2016/03/16/business/16valeantsub/16valeantsub-articleLarge.jpg", "legacy": {"xlarge": "images/2016/03/16/business/16valeantsub/16valeantsub-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "400"}, "width": 600, "subtype": "xlarge", "height": 400}, {"type": "image", "url": "images/2016/03/16/business/16valeantsub/16valeantsub-thumbStandard.jpg", "legacy": {"thumbnail": "images/2016/03/16/business/16valeantsub/16valeantsub-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "width": 75, "subtype": "thumbnail", "height": 75}], "headline": {"kicker": "Breakingviews", "content_kicker": "Breakingviews", "main": "Valeant\u2019s Struggles Could Lead It to Crumble"}, "print_page": null, "keywords": [{"value": "Appointments and Executive Changes", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Valeant Pharmaceuticals International Inc", "is_major": "N", "rank": "2", "name": "organizations"}, {"value": "Ackman, William A", "is_major": "N", "rank": "3", "name": "persons"}, {"value": "Pearson, John Michael (1959- )", "is_major": "N", "rank": "4", "name": "persons"}, {"value": "Schiller, Howard B", "is_major": "N", "rank": "5", "name": "persons"}, {"value": "Accounting and Accountants", "is_major": "N", "rank": "6", "name": "subject"}, {"value": "Pershing Square Capital Management", "is_major": "N", "rank": "7", "name": "organizations"}], "snippet": "The drug maker revealed accounting issues, a search for a new chief executive and new board seats as it struggles with debt and a falling stock price.", "source": "The New York Times", "lead_paragraph": "The drug maker revealed accounting issues, a search for a new chief executive and new board seats as it struggles with debt and a falling stock price.", "word_count": "358", "pub_date": "2016-03-22T00:00:00Z", "subsection_name": "DealBook", "blog": [], "type_of_material": "News", "section_name": "Business Day", "web_url": "http://www.nytimes.com/2016/03/22/business/dealbook/valeants-struggles-could-lead-it-to-crumble.html", "_id": "56f0432338f0d82d2a6d5d28"}